Varex Imaging (NASDAQ:VREX) Director Jay K. Kunkel Sells 2,575 Shares

Varex Imaging (NASDAQ:VREX - Get Free Report) Director Jay K. Kunkel sold 2,575 shares of Varex Imaging stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $7.77, for a total transaction of $20,007.75. Following the completion of the sale, the director now owns 22,477 shares of the company's stock, valued at $174,646.29. This represents a 10.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Varex Imaging Stock Up 1.0%

Shares of NASDAQ VREX traded up $0.08 during midday trading on Monday, hitting $7.83. 276,929 shares of the stock traded hands, compared to its average volume of 563,819. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.36 and a current ratio of 4.05. Varex Imaging has a one year low of $6.76 and a one year high of $16.93. The business has a 50 day moving average price of $7.96 and a two-hundred day moving average price of $11.27. The company has a market cap of $322.60 million, a PE ratio of -7.60 and a beta of 0.66.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.08% and a positive return on equity of 4.91%. The business had revenue of $212.90 million during the quarter, compared to analyst estimates of $206.76 million. During the same quarter in the previous year, the business posted $0.16 EPS. Varex Imaging's quarterly revenue was up 3.3% on a year-over-year basis. On average, equities analysts predict that Varex Imaging will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on VREX. Wall Street Zen cut shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. B. Riley raised shares of Varex Imaging to a "strong-buy" rating in a research report on Monday, May 12th.

Institutional Investors Weigh In On Varex Imaging

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Aquatic Capital Management LLC acquired a new position in Varex Imaging during the 4th quarter valued at about $25,000. Quadrant Capital Group LLC raised its position in Varex Imaging by 115.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock valued at $41,000 after buying an additional 1,520 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in Varex Imaging during the 4th quarter valued at $48,000. Quarry LP bought a new position in shares of Varex Imaging during the first quarter valued at about $63,000. Finally, KLP Kapitalforvaltning AS purchased a new position in shares of Varex Imaging in the 4th quarter worth approximately $98,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.